Anebulo Pharmaceuticals, Inc. (ANEB)
Largest Insider Buys in Sector
ANEB Stock Price History Chart
ANEB Stock Performance
About Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
Insider Activity of Anebulo Pharmaceuticals, Inc.
Over the last 12 months, insiders at Anebulo Pharmaceuticals, Inc. have bought $10M and sold $0 worth of Anebulo Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Anebulo Pharmaceuticals, Inc. have bought $5.05M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: English Aron R. () — $30M.
The last purchase of 10,101,010 shares for transaction amount of $10M was made by English Aron R. () on 2024‑12‑23.
List of Insider Buy and Sell Transactions, Anebulo Pharmaceuticals, Inc.
| 2024-12-23 | 10.1M 30.1255% | $0.99 | $10M | +29.60% | ||||
| 2021-12-17 | 400 0.0016% | $6.59 | $2,634 | -43.79% | ||||
| 2021-12-14 | 412 0.0015% | $5.89 | $2,429 | -40.48% | ||||
| 2021-12-03 | 4,500 0.0153% | $5.93 | $26,685 | -42.67% | ||||
| 2021-12-02 | 13,836 0.0441% | $5.30 | $73,331 | -39.35% |
Insider Historical Profitability
| English Aron R. | 15467300 37.6473% | $1.59 | 5 | 0 | <0.0001% |